Menu
November 29, 2021 | By Haley Wilson | Clinical Research, NAFLD | Blog, Clinical trials, Fatty Liver Disease, liver health
In the medical world, we are always trying to find new ways to treat all kinds of conditions. Non-alcoholic fatty liver disease, or NAFLD, is a condition that we are constantly learning more about, especially in the work of clinical research. NAFLD has emerged as the most prominent cause of chronic liver disease. So what’s new in NAFLD research? Let’s find out!
NAFLD researchers are urging the public to take care of themselves by declaring NAFLD as a public health priority. They are realizing that the general public does not possess proper knowledge of NAFLD and they desire to change that. At the Digital NAFLD Summit 2021, researchers developed a final set of 37 consensus statements and 26 recommendations. The statements addressed a broad range of topics relevant to policymakers, practitioners, civil society groups, researchers, and affected populations. They hope that these recommendations can bring major change to NAFLD basic knowledge and prevention.
Anyone can develop NAFLD. Unfortunately, we don’t know everything about this condition. However, clinical research has provided a lot of information about who can get it or what causes fatty liver. We do know that it is more common for people that have the following factors:
There is no medication or vaccine approved by the FDA to treat NAFLD. Fortunately, there are ways in which you can reduce or prevent fatty liver. Common suggestions from physicians include:
NAFLD clinical research is so crucial today. We need clinical trials to develop treatments for NAFLD and you can help us. Participate in clinical trials to help the advancement in medicine for NAFLD. You can sign up for our current or upcoming studies by calling us at (480) 360-4000 or visiting our website.
Sources:
https://www.healio.com/news/hepatology/20210917/researchers-deem-nafld-a-public-health-priority